Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid

Last updated: February 10, 2026
Sponsor: Lo.Li.Pharma s.r.l
Overall Status: Active - Recruiting

Phase

N/A

Condition

Uterine Fibroids

Desmoid Tumors

Sarcoma (Pediatric)

Treatment

Epigallocatechin gallate, Vitamin D, Vitamin B6, D-chiro-inositol

Placebo

Clinical Study ID

NCT05448365
DELPHYS PLUS
  • Ages 30-40
  • Female

Study Summary

The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6.

The patients will be evaluated at baseline and after three months of treatment with placebo or product.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. uterine fibroid with diameter greater than or equal to 4cm or multiple fibroids

  2. eligible for surgery

  3. symptoms like menometrorrhagia or pelvic pain

Exclusion

Exclusion Criteria:

  1. BMI>30

  2. currently pregnant or breastfeeding

  3. diabetic

  4. suspect of malignancy

  5. diagnosis of cancer

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Epigallocatechin gallate, Vitamin D, Vitamin B6, D-chiro-inositol
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
July 01, 2026

Connect with a study center

  • Ospedale Dario camberlingo

    Francavilla Fontana 3176603, Apulia 3169778 72021
    Italy

    Active - Recruiting

  • Ospedale Veris Delli Ponti

    Scorrano 3166872, Apulia 3169778 73020
    Italy

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.